Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced a strategic ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

A new computational approach has uncovered possible drugs for specific cellular targets in glioblastoma, enabling the ...

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

Nucleosomes are barriers to RNA Polymerase II (Pol II) transcribing along gene bodies in eukaryotes. We found that a fragile “tailless nucleosome” could be generated to resolve the Pol II pausing ...

Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 –-- ...

WASHINGTON – Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating ...

Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 - -- Expects to initiate global Phase 1/2 MAD clinical study ...

Getting ready for pregnancy? Don’t forget this essential check: your folic acid levels. It’s a small step that plays a big role in early baby development.

A few months after releasing the GB10-based DGX Spark workstation, NVIDIA uses CES 2026 to showcase super-charged performance ...

Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor.  This approach enabled them to ...